|
Match
|
Document |
Document Title |
|
|
7037528 |
Microprecipitation method for preparing submicron suspensions
The present invention provides a method for preparing submicron sized particles of an organic compound, the solubility of which is greater in a water-miscible first solvent than in a second solvent...
|
|
|
7037519 |
Nutritional supplement and methods of making
Nutritional supplements and methods for making same supplement the intake of nutrition from foods. Garlic and apple cider vinegar are currently available in separate forms and are popular with...
|
|
|
7037513 |
Bodywash additives
The invention encompasses additives for addition to a composition for topical application, e.g., a bodywash, where the additive contains an encapsulated non-sunscreen, and methods of making and...
|
|
|
7033600 |
Inverse latex and use in cosmetics
A cosmetic, dermopharmaceutical or pharmaceutical composition includes a composition containing an oil phase, an aqueous phase, a water-in-oil (W/O) emulsifier, an oil-in-water (O/W) emulsifier, in...
|
|
|
7033579 |
Anhydrous antiperspirant and deodorant compositions containing solid vitamin B3 particulates and glycerin
Disclosed are anhydrous antiperspirant and deodorant compositions that comprise from about 0.1% to about 30% by weight of an antiperspirant or deodorant active; from about 0.01% to about 20% by...
|
|
|
7033577 |
In vitro prediction of sunscreen PFA values
An in vitro method for the prediction of in vivo UVA protection by a composition with sunscreen properties. The method includes the steps of: determining in vivo SPF; determining in vitro SPF based...
|
|
|
7033582 |
Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
The present invention involves the administration of Copolymer 1 (glatiramer acetate) to treat inflammatory, non-autoimmune central nervous system (CNS) diseases, alleviate the symptoms thereof,...
|
|
|
7033571 |
Multiple stimulus reversible hydrogels
A polymeric solution capable of gelling upon exposure to a critical minimum value of a plurality of environmental stimuli is disclosed. The polymeric solution may be an aqueous solution utilized in...
|
|
|
7033598 |
Methods and apparatus for enhanced and controlled delivery of a biologically active agent into the central nervous system of a mammal
Disclosed are invasive and non-invasive central nervous system (CNS) drug delivery methods and devices for use in these methods that essentially circumvent the blood-brain barrier. More...
|
|
|
7030104 |
Topical oestroprogestational compositions with a systemic effect
The present invention relates to the field of therapeutic chemistry and more especially to the realization of new galenic forms intended to be applied on the skin. More particularly it relates to...
|
|
|
7030094 |
Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21
The invention provides pharmaceutical compositions, particularly vaccine compositions, employing an adjuvant system comprising RC-529 (an aminoalkyl glucosaminide phosphate compound) and QS-21 (a...
|
|
|
RE39072 |
2-aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same
The present invention relates to a compound of the general formula
wherein R 1 , R 2 , R 3 and R 4 are each a hydrogen or an acyl, a pharmaceutically acceptable acid addition salt thereof or...
|
|
|
7029663 |
Stable ointment containing acetylsalicylic acid
A substantially anhydrous stable ointment containing Aspirin which is characterized in using gelation hydrocarbon and/or vaseline as a base. The ointment is superior in stability and can be stored...
|
|
|
7025952 |
Methods of preparation and use of bodywashes containing additives
The invention encompasses methods of use of bodywashes containing additive to modify skin, e.g., protection of skin from sunlight by application of a bodywash containing a sunscreen. Thus, in one...
|
|
|
7025973 |
Acid cosmetic, dermatological and pharmaceutical agents
The invention provides acidic cosmetic, dermatological, and pharmaceutical agents comprising at least one copolymer obtainable by free-radical copolymerization of
A) acryloyldimethyltaurine and/or...
|
|
|
7025965 |
Method of use and dosage composition of bluegreen algae extract for inflammation in animals
A means and method for treating inflammation and pain in animals is described. The compounds include phycocyanin in a pharmaceutically acceptable carrier. Phycocyanin has been found to be a COX-2...
|
|
|
7025984 |
Compositions and methods for body weight management
The present invention is for compositions and methods for managing the body weight of a subject using said compositions. Weight management, particularly weight gain and loss, is effectuated by...
|
|
|
7025974 |
Absorbent product containing absorbent structure and bacillus coagulans
The invention describes compositions and methods for inhibiting microbial infections associated with the use of sanitary products, such as diapers, bandages, sanitary napkins, tampons and the like....
|
|
|
7025975 |
Galenical formulations
A pharmaceutical composition containing macrolide, e.g. a rapamycin compound in an emulsion preconcentrate or microemulsion preconcentrate for oral administration. The carrier medium for the...
|
|
|
7025983 |
Fast dissolving orally consumable films
Physiologically acceptable films, including edible films, are disclosed. The films include a water soluble film-forming polymer such as pullulan. Edible films are disclosed that include pullulan...
|
|
|
7025979 |
Male contraceptive formulation comprising norethisterone
A formulation for male contraception comprising a progestin possessing both estrogenic and androgenic properties is remarkably effective for spermatogenesis suppression in males. The progestin...
|
|
|
7025989 |
Multiple-delayed released antibiotic product, use and formulation thereof
An antibiotic product is comprised of at least three delayed release dosages forms, each of which has a different release profile, with the C max for the antibiotic product being reached in less...
|
|
|
7022347 |
Restorative and grafting material for hard tissue defects prepared from animal teeth
The restorative and grafting material for reconstruction of hard tissue defects and the fabrication method of the same are provided. In particular, the restorative and grafting material of this...
|
|
|
7022316 |
Non-pilling UV-photoprotecting sunscreen compositions
Topically applicable, non-pilling UV-photoprotecting cosmetic/dermatological sunscreen compositions, advantageously alcoholic sunscreen gels, well suited for UV-photoprotecting human skin and/or...
|
|
|
7022330 |
Parenteral formulation for epothilone analogs
A process for formulating certain epothilone analogs for parenteral administration is disclosed wherein the analog is dissolved in a mixture of at least 50% by volume tertiary-butanol in water, the...
|
|
|
7022343 |
Controlled release of anti-arrhythmic agents
Methods for the simple, reliable application and local controlled release of selected anti-arrhythmia drugs from a hydrogel applied to or polymerized on the tissues of the heart or its vessels,...
|
|
|
7022318 |
Kit of parts for treating urinary incontinence in mammals
Disclosed are methods for treating urinary incontinence in a mammal wherein a composition comprising a biocompatible polymer, a biocompatible solvent, and a contrast agent is delivered to the...
|
|
|
7018648 |
Transdermal device for administering testosterone or one of the derivatives thereof
The invention relates to a self-adhesive transdermal device for the administration of testosterone and/or at least one of the derivatives thereof, comprising successively at least one support...
|
|
|
7018623 |
B complex vitamin compositions that protect against cellular damage caused by ultraviolet light
The present invention relates generally to the use of vitamin B12 (cobalamin or cyanocobalamin) alone or in combination with other photoprotective agents, including specifically other vitamins such...
|
|
|
7014842 |
Sunscreen composition
There is provided a composition comprising one or more photoactive compounds and one or more optimization agents. Surprisingly, the composition requires a small amount of optimization agent to...
|
|
|
7014864 |
Formulations comprising lipid-regulating agents
The present invention is directed to a formulation comprising a lipid-regulating agent dissolved in at least one structured lipid as the primary solvent medium for said agent. One or more...
|
|
|
7014865 |
Natural formulation for the treatment and prevention of depression, containing St. John's Wort and derivatives of dihydro- and tetrahydrofolic acid
The present invention relates to novel compositions containing a combination of the plant St. John's Wort ( Hypericum perforatum L.), its extracts of active ingredients and derivatives of dihydro-...
|
|
|
7014843 |
Enhanced efficacy basic aluminum halides/metal cation salt, antiperspirants actives and compositions containing such materials and methods for making
Disclosed are aqueous antiperspirant active compositions comprising an admixtures of basic aluminum halides and a metal cation salts which yield enhanced antiperspirant efficacy; and methods of...
|
|
|
7012101 |
Artificial tanning emulsions comprising sorghum extracts/organomodified silicones
Topically applicable, cosmetic/dermatological artificial tanning emulsions devoid of certain flavylium salts include (a) at least one aqueous phase and (b) at least one fatty phase, (c) an...
|
|
|
RE39014 |
Packaging and method for solid dose administration of medicaments
A method and packaging for vaccinating or medicating an animal by implanting a solid dose medicament in an animal. The solid dose medicament, or plurality of such medicaments, are each color-coded...
|
|
|
7011968 |
Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients
The invention relates to a synthetic, biologically active molecule for fixing an active ingredient to the virus protein 1 (VP1) of the polyoma virus. According to the invention, an amino acid...
|
|
|
7011822 |
Effective soft solid personal care product
A low residue antiperspirant and/or deodorant composition in the form of an anhydrous, surfactant-free and antiseptic alcohol-free suspension exhibiting a syneresis of less than 8% which is made by...
|
|
|
7011841 |
High density porous materials
Porous materials are disclosed having densities of at least about 6 pounds per cubic foot (96.1 kg/m 3 ). The materials comprise silica and/or alumina. The porous materials are useful as supports...
|
|
|
7008618 |
Water soluble monomers and polymers for protecting substrates from ultraviolet light
A UV-protective composition for treating substrates comprising one or more water-soluble, cationic, UV-absorbing polymers, wherein the cationic, UV-absorbing polymers are prepared by polymerizing...
|
|
|
7008635 |
Hydrogels for orthopedic repair
Hydrogels intended for orthopedic applications, including repair and regeneration of cartilage, bone, joint surfaces and related tissues, must possess greater strength and toughness than hydrogels...
|
|
|
7008630 |
Lipochroman-6 as NO-synthase inhibitor and uses
The invention concerns relates to the use of an efficient amount of lipochroman-6, in a physiologically acceptable medium, in a composition or for preparing a composition, the lipochroman-6 or the...
|
|
|
7008647 |
Treatment of acne
The invention relates to the use of one or more antimicrobial metals selected from silver, gold, platinum, and palladium but most preferably silver, preferably formed with atomic disorder, and...
|
|
|
7008620 |
Depilatory compositions and articles and the use thereof
The present invention relates to a composition or article containing at least one oxidizing agent and at least one reducing agent, wherein at least one of the at least one reducing agent is a...
|
|
|
7008626 |
Medical composition for protuberance of epithelium
A medical composition for protuberance of epithelium, which comprises a solution comprising a polysaccharide or a medically acceptable salt thereof, wherein the solution has a viscosity of: (1)...
|
|
|
7005133 |
Composition and process for treating pollution
A composition for treatment of pollution comprises a first component comprising a carbon containing substance in an oil phase and a second component comprising a nutrient in a water phase, the...
|
|
|
7004321 |
Cumulative packaging provided for the removal of filled pouches in a predetermined order
The invention relates to a packaging of products which are additionally packed in a pouch ( 2 ) in order to protect the same, whereby the packaging is comprised of at least two pouches. The...
|
|
|
7005132 |
Prodrug compositions and drug delivery methods using synthetic receptors
The present invention provides prodrug and multiprodrug complexes comprising drugs specifically bound to synthetic receptors in such a manner that active drug becomes available only in the presence...
|
|
|
7001619 |
Hepatocurative effect of emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs
The present invention relates to a composition useful for hepatocurative effect against CYP 450 bio-activation hepatotoxicity induced by drugs, said composition comprising an extract from Emblica...
|
|
|
7001594 |
Scalp cosmetic compositions and corresponding methods of application to provide scalp moisturization and skin active benefits
Disclosed are topical leave-on cosmetic compositions, including packaged leave-on compositions, for direct application to the scalp, comprising a) from about 40% to about 99% by weight of a...
|
|
|
7001617 |
Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
The invention relates to a method to induce apoptosis and to inhibit matrix metalloproteinases in a disease condition in a human or animal by contacting hyperplastic tissue, tumor tissue, or a...
|